211 related articles for article (PubMed ID: 34296786)
21. Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures.
Robertson SJ; Mitzel DN; Taylor RT; Best SM; Bloom ME
Immunol Res; 2009; 43(1-3):172-86. PubMed ID: 18841330
[TBL] [Abstract][Full Text] [Related]
22. The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model.
Takaki H; Takeda M; Tahara M; Shingai M; Oshiumi H; Matsumoto M; Seya T
J Immunol; 2013 Nov; 191(9):4740-7. PubMed ID: 24078691
[TBL] [Abstract][Full Text] [Related]
23. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.
Yoshii K; Sunden Y; Yokozawa K; Igarashi M; Kariwa H; Holbrook MR; Takashima I
J Virol; 2014 May; 88(10):5406-20. PubMed ID: 24574402
[TBL] [Abstract][Full Text] [Related]
24. Cellular stress is triggered by tick-borne encephalitis virus and limits the virus replication in PMJ2-R mouse macrophage cell line.
Beránková Z; Khanna R; Spěváková M; Langhansová H; Kopecký J; Lieskovská J
Ticks Tick Borne Dis; 2024 Jan; 15(1):102269. PubMed ID: 37813002
[TBL] [Abstract][Full Text] [Related]
25. TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase.
Taylor RT; Lubick KJ; Robertson SJ; Broughton JP; Bloom ME; Bresnahan WA; Best SM
Cell Host Microbe; 2011 Sep; 10(3):185-96. PubMed ID: 21925107
[TBL] [Abstract][Full Text] [Related]
26. Characterization of neutralizing monoclonal antibody against tick-borne encephalitis virus in vivo.
Matveev A; Matveev L; Stronin O; Baykov I; Emeljanova L; Khlusevich Y; Tikunova N
Vaccine; 2020 Jun; 38(27):4309-4315. PubMed ID: 32409136
[TBL] [Abstract][Full Text] [Related]
27. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium.
Broquet AH; Hirata Y; McAllister CS; Kagnoff MF
J Immunol; 2011 Feb; 186(3):1618-26. PubMed ID: 21187438
[TBL] [Abstract][Full Text] [Related]
28. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664
[TBL] [Abstract][Full Text] [Related]
29. Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.
Etna MP; Signorazzi A; Ricci D; Severa M; Rizzo F; Giacomini E; Gaggioli A; Bekeredjian-Ding I; Huckriede A; Coccia EM
PLoS Pathog; 2021 Apr; 17(4):e1009505. PubMed ID: 33857267
[TBL] [Abstract][Full Text] [Related]
30. Tick-borne encephalitis virus infects rat astrocytes but does not affect their viability.
Potokar M; Korva M; Jorgačevski J; Avšič-Županc T; Zorec R
PLoS One; 2014; 9(1):e86219. PubMed ID: 24465969
[TBL] [Abstract][Full Text] [Related]
31. Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection.
Blom K; Cuapio A; Sandberg JT; Varnaite R; Michaëlsson J; Björkström NK; Sandberg JK; Klingström J; Lindquist L; Gredmark Russ S; Ljunggren HG
Front Immunol; 2018; 9():2174. PubMed ID: 30319632
[TBL] [Abstract][Full Text] [Related]
32. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
[TBL] [Abstract][Full Text] [Related]
33. Tick-borne encephalitis virus NS4A ubiquitination antagonizes type I interferon-stimulated STAT1/2 signalling pathway.
Yang Q; You J; Zhou Y; Wang Y; Pei R; Chen X; Yang M; Chen J
Emerg Microbes Infect; 2020 Dec; 9(1):714-726. PubMed ID: 32196427
[TBL] [Abstract][Full Text] [Related]
34. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
Hwang M; Bergmann CC
J Virol; 2018 May; 92(10):. PubMed ID: 29491163
[TBL] [Abstract][Full Text] [Related]
35. Langat virus infection affects hippocampal neuron morphology and function in mice without disease signs.
Cornelius ADA; Hosseini S; Schreier S; Fritzsch D; Weichert L; Michaelsen-Preusse K; Fendt M; Kröger A
J Neuroinflammation; 2020 Sep; 17(1):278. PubMed ID: 32951602
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection.
Kirsebom FCM; Kausar F; Nuriev R; Makris S; Johansson C
Mucosal Immunol; 2019 Sep; 12(5):1244-1255. PubMed ID: 31358860
[TBL] [Abstract][Full Text] [Related]
37. Innate and adaptive immunity in wild rodents spontaneously and experimentally infected with the tick-borne encephalitis virus.
Morozova OV; Panov VV; Bakhvalova VN
Infect Genet Evol; 2020 Jun; 80():104187. PubMed ID: 31927073
[TBL] [Abstract][Full Text] [Related]
38. Cell-type- and region-specific restriction of neurotropic flavivirus infection by viperin.
Lindqvist R; Kurhade C; Gilthorpe JD; Överby AK
J Neuroinflammation; 2018 Mar; 15(1):80. PubMed ID: 29544502
[TBL] [Abstract][Full Text] [Related]
39. Both TRIF and IPS-1 adaptor proteins contribute to the cerebral innate immune response against herpes simplex virus 1 infection.
Menasria R; Boivin N; Lebel M; Piret J; Gosselin J; Boivin G
J Virol; 2013 Jul; 87(13):7301-8. PubMed ID: 23596298
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection.
Tang J; Fu M; Xu C; Xue B; Zhou A; Chen S; Zhao H; Zhou Y; Chen J; Yang Q; Chen X
Virol Sin; 2023 Oct; 38(5):767-777. PubMed ID: 37328107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
